For citations:
Kurenkov A.L., Agranovich O.V., Kuzenkova L.M., Khachatryan L.G., Kenis V.M., Zherebtsova V.A., Sarzhina M.N., Odinaeva N.D., Artemenko A.R., Popova G.A., Moroshek E.A., Bursagova B.I., Chernikov V.V., Tabe E.E., Nezhelskaya A.A., Maksimenko A.A., Akhadova L.Ya., Indereykin M.V., Duibanova N.V., Tikhonova L.V., Sapogovsky A.V., Gadzhialieva Z.M., Grigorieva A.V., Perminov V.S., Fedonyuk I.D., Kolpakchi L.M., Kursakova Yu.A., Tsurina N.A. Dose selection of Incobotulinumtoxin A for the treatment of spasticity and sialorrhea in cerebral palsy: results of a retrospective multicenter study. L.O. Badalyan Neurological Journal. 2021;2(4):189-202. (In Russ.) https://doi.org/10.46563/2686-8997-2021-2-4-189-202
Email this article 
